Esmon C T
Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City.
Thromb Haemost. 1993 Jul 1;70(1):29-35.
Despite its rather recent identification, the protein C activation system has afforded many investigators with unique opportunities to probe the molecular basis by which cofactors function. Thrombomodulin clearly exerts its specificity switch both by interacting directly with the fibrinogen binding site on thrombin (exosite 1) and by altering the conformation within the enzyme center. At least in the case of thrombomodulin, these conformational changes appear to overcome repulsive interactions between acidic residues in the substrate and the enzyme. To determine whether the models derived from attempts at the molecular analysis of the protein C activation complex are at all relevant to the other coagulation complexes will require further examination, but the concept that residues near the cleavage site contact residues in the free enzyme in an unfavorable fashion, and that the cofactors overcome these inhibitory interactions is a hypothesis that is directly testable for all of the complexes. The availability of crystal structures for the coagulation enzymes, coupled with the capacity to mutagenize both the substrate and the enzyme, promises to provide new insights into molecular events that control coagulation.
尽管蛋白C激活系统是最近才被发现的,但它为许多研究人员提供了独特的机会,以探究辅因子发挥作用的分子基础。血栓调节蛋白显然通过直接与凝血酶上的纤维蛋白原结合位点(外位点1)相互作用以及改变酶中心内的构象来发挥其特异性开关的作用。至少在血栓调节蛋白的情况下,这些构象变化似乎克服了底物中酸性残基与酶之间的排斥相互作用。要确定从对蛋白C激活复合物的分子分析尝试中得出的模型是否与其他凝血复合物完全相关,还需要进一步研究,但是这样一种概念,即切割位点附近的残基以不利的方式与游离酶中的残基接触,并且辅因子克服了这些抑制性相互作用,是一个对所有复合物都可直接进行检验的假设。凝血酶的晶体结构的可得性,再加上对底物和酶进行诱变的能力,有望为控制凝血的分子事件提供新的见解。